Skip to main content
OpenTrials

Clinical trial condition

Recurrent Diffuse Intrinsic Pontine Glioma

Explore clinical trials studying Recurrent Diffuse Intrinsic Pontine Glioma. Study availability and eligibility vary by location and protocol.

7 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Diffuse Intrinsic Pontine Glioma trial results

Recruiting

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

NCT05278208

Conditions
Anaplastic Ependymoma, Brain Diseases, Brain Neoplasms, +32 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

Combination Therapy for the Treatment of Diffuse Midline Gliomas

NCT05009992

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +20 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California, San Diego / Rady Children's Hospital, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 32 locations
View Trial Details
Recruiting

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

NCT04870944

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +31 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
View all 35 locations
View Trial Details
Completed

Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors

NCT03387020

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +27 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children Hospital Stanford University Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View Trial Details
Active, Not Recruiting

Savolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors

NCT03598244

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +25 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View Trial Details
Active, Not Recruiting

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma

NCT02359565

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +46 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View Trial Details

Related conditions